The use of hormonal contraceptive agents and mood disorders in women

被引:33
|
作者
Svendal, Gjertrud [1 ,2 ]
Berk, Michael [3 ,4 ,5 ,6 ]
Pasco, Julie A. [7 ,8 ]
Jacka, Felice N. [3 ,4 ]
Lund, Anders [1 ,2 ]
Williams, Lana J. [3 ,4 ]
机构
[1] Univ Bergen, Dept Clin Med, Sect Psychiat, N-5020 Bergen, Norway
[2] Haukeland Hosp, MoodNet Res Grp, N-5021 Bergen, Norway
[3] Deakin Univ, Barwon Psychiat Res Unit, Sch Med, Geelong, Vic 3220, Australia
[4] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia
[5] Orygen Youth Hlth Res Ctr, Parkville, Vic, Australia
[6] Mental Hlth Res Inst, Parkville, Vic, Australia
[7] Deakin Univ, Sch Med, Barwon Epidemiol & Biostat Unit, Geelong, Vic 3220, Australia
[8] Univ Melbourne, NW Acad Ctr, Dept Med, St Albans, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
Mood disorders; Contraceptive agents; Progestogen; Estrogen; Hormones; Depression; MAJOR DEPRESSIVE DISORDER; ORAL-CONTRACEPTIVES; AUSTRALIAN WOMEN; PROGESTERONE; RECEPTOR; SYMPTOMS; ESTROGEN; COHORT;
D O I
10.1016/j.jad.2012.03.030
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Mood disorders are a major cause of disability in developed countries, and contraceptive agents among the most widely used medications. The relationship between contraceptive agents and mood is unclear. The aim of this study was therefore to investigate the association between current contraception use and mood disorders in a random population-based sample of women. Methods: This study examined epidemiological data obtained from 498 women aged 20-50 year participating in the Geelong Osteoporosis Study (GOS). Mood disorders were diagnosed using a clinical interview (SCID-I/NP) and information on medication use and other lifestyle factors were documented. Results: After adjusting for age and socioeconomic status (SES), women taking progestin-only contraceptive agents had an increased likelihood of a current mood disorder (OR 3.0 95%Cl: 1.1-7.8, p = 0.03). In contrast, women taking combined contraceptive agents had a decreased likelihood of a current mood disorder, adjusting this for age and SES (OR 0.3 95%Cl: 0.1, 0.9 p=0.03). These findings were not explained by weight, physical activity level, past depression, number of medical conditions or cigarette smoking. Limitations: This study is cross-sectional, which precludes any determination regarding the direction of the relationships. Conclusions: These data suggest a protective effect of the combined contraceptive pill, and a deleterious effect of progestin only agents in regards to mood disorders. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:92 / 96
页数:5
相关论文
共 50 条
  • [21] Hormonal contraceptive use among women with liver tumors: a systematic review
    Kapp, Nathalie
    Curtis, Kathryn M.
    CONTRACEPTION, 2009, 80 (04) : 387 - 390
  • [22] Nocturnal Heart Rate Variability in Women Discordant for Hormonal Contraceptive Use
    Ahokas, Essi K.
    Hanstock, Helen G.
    Lofberg, Ida
    Nyman, Mari
    Wenning, Piia
    Kyrolainen, Heikki
    Mikkonen, Ritva S.
    Ihalainen, Johanna K.
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2023, 55 (07) : 1342 - 1349
  • [23] Hormonal Contraceptive Use Among Canadian Pre-menopausal Women
    Campbell, Allison
    Liva, Sarah
    Claydon, Victoria
    Cote, Anita
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2022, 54 (09) : 341 - 341
  • [24] The association between hormonal contraceptive use and glaucoma in women of reproductive age
    Hogden, Kate
    Mikelberg, Frederick
    Sodhi, Mohit
    Khosrow-Khavar, Farzin
    Mansournia, Mohammad Ali
    Kezouh, Abbas
    Etminan, Mahyar
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (12) : 4780 - 4785
  • [25] Mood disorders and hormonal status across women's life: a narrative review
    Antonelli, Alice
    Giannini, Andrea
    Chedraui, Peter
    Monteleone, Patrizia
    Caretto, Marta
    Genazzani, Alessandro D.
    Mannella, Paolo
    Simoncini, Tommaso
    Genazzani, Andrea R.
    GYNECOLOGICAL ENDOCRINOLOGY, 2022, 38 (12) : 1019 - 1027
  • [26] HORMONAL WINDOWS OF VULNERABILITY FOR MOOD DISORDERS
    Andreano, Joseph
    Barrett, Lisa Feldman
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S321 - S321
  • [27] LIVER-FUNCTION IN THAI WOMEN USING DIFFERENT TYPES OF HORMONAL CONTRACEPTIVE AGENTS
    DUSITSIN, N
    TANKEYOON, M
    LARSSONCOHN, U
    JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, 1978, 61 (07): : 381 - 389
  • [28] New Hormonal Contraceptive Agents during Lactation
    Anderson, Philip O.
    BREASTFEEDING MEDICINE, 2023, 18 (10) : 734 - 736
  • [29] Pharmacologic Development of Male Hormonal Contraceptive Agents
    Roth, M. Y.
    Amory, J. K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (01) : 133 - 136
  • [30] SAFETY AND SIDE EFFECTS WITH INVESTIGATIONAL CONTRACEPTIVE PATCH USE IN WOMEN WITH AND WITHOUT HORMONAL CONTRACEPTIVE EXPERIENCE.
    Castano, P. M.
    Simon, J. A.
    Chen, B. A.
    Flood, L.
    Previtera, M.
    Chiodo, J.
    Garner, E. I.
    FERTILITY AND STERILITY, 2018, 110 (04) : E285 - E285